Diabetes Care in The Netherlands: - Novo Nordisk

More documents

Recommendations

Info

Medical costs costs and and lost lost productivity of diabetes of patients could could riseto rise ~ EUR to ~ 16-19 EUR B 16-19 BTotal cost of Diabetes to SocietyEUR B , 2010-202016-196.5Lost productivity disabled10-113.54.8Welfare payments2.60.21.81.31.220100.52.31.71.62020Absenteeism & presenteeismOther medical costCost of complicationsDirect medical costSource: Source: RIVM, Booz RIVM, & Booz Company & Company Analysis AnalysisBooz & Company 14 November 2011Prepared for Novo Nordisk1724
Increase in lost productivity is driven by an increasing number ofdiabetes patients in workforce (~380k in 2020)Increase in lost productivity is driven by an increasing number ofIncrease and breakdown of diabetes patients in workforce2010 - 2020, ‘000• Disability estimates based on welfareregistration of the UWV• Reflects the number of disabled with diabetesBACK -UPYounger diabetic populationRetirement age 67Net increase patients ’10 – ‘20261117202275~3801892424Working withdisability assumed30% disabled1412010Total workforcediabetes patientsIncrease ’10to ’202020Number ofdiabeticsin workforceWorking withwith nodisabilityWorking withdisabilitywithoutadjustmentsWorking withdisabilitywith adjustmentsOne out of three new diabetes patients in the workforce will beType 1 patientsNot ableto workSource:CBS, UWV, Booz & Company AnalysisBooz & Company 14 November 2011Prepared for Novo Nordisk1825
Page 6 and 7: SummaryDiabetes is a serious and de
Page 8: diabetes care. Extra compensation w
Page 11 and 12: ContentsSummarized findings and rec
Page 13 and 14: 11Diabetes is a major and underesti
Page 15 and 16: 33Further improving health of of di
Page 17 and 18: 22Recommendation 2: Engage employer
Page 19 and 20: 44Recommendation 4: Introduce condi
Page 21 and 22: Already more than 1M diabetes patie
Page 23 and 24: Costs of of complications and treat
Page 25: Number of patients reaches ~1.4M in
Page 29 and 30: Diabetes care clearly improved in t
Page 31 and 32: Better compliance can be stimulated
Page 37 and 38: Delaying complications saves medica
Page 39 and 40: LimitedLimitedcollaborationcollabor
Page 41 and 42: Individual quality incentives are l
Page 43 and 44: Recommendation 1: Insurer should in
Page 47 and 48: Labour shortage from late nineties
Page 49 and 50: However, curative and participative
Page 53 and 54: Non-compliance leads to severe comp
Page 55: Facilitated patient networks are su
Page 58 and 59: Recommendation 3:Facilitate network
Page 62 and 63: But new medication could add a lot
Page 66: Booz & Company is a global manageme

Diabetes Care in The Netherlands: - Novo Nordisk

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?